newsfilter
← Latest News
GlobeNewswire·

LexaGene's MiQLab System Detects Mycoplasma at Minute Levels, Rousing Additional Interest from BioPharma Customers

BEVERLY, Mass., Jan. 18, 2023 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB:LXXGF, TSXV:LXG) ("LexaGene" or the "Company"), an innovative, molecular diagnostics company that has commercialized the MiQLabTM System